CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Reactogenicity Study of a New Formulation of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00611559
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:54.768898+00:00
Published At: 2009-08-10T00:00:00+00:00
Record Updated At: 2018-06-06
Results Posted At: 2009-08-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Poliomyelitis", "Acellular Pertussis", "Tetanus", "Diphtheria", "Hepatitis B"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-06-06"
protocolSection.identificationModule.nctId: "NCT00611559"
protocolSection.identificationModule.officialTitle: "Immunogenicity and Reactogenicity Study of a New Formulation of GSK Biologicals\u0027 DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2009-08-10"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.